VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | The promise of pelabresib in MF and insights into the MANIFEST-2 study

In this video, Andrew Kuykendall, MD, H. Lee Moffitt Cancer Center, Tampa, FL, discusses the promising role of pelabresib in myelofibrosis (MF), and shares some insights into the excitement surrounding the ongoing Phase III MANIFEST-2 study (NCT04603495). This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Research fees – Morphosys, GSK
Honoraria – Incyte

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter